Recent News
October 17-21, 2017 – ASHG American Society of Human Genetics
EpigenDx will be attending the annual ASHG American Society of Human Genetics meeting in Orlando, FL.
Booth #: 828
April 1-5, 2017 – AACR American Association for Cancer Research
EpigenDx will be attending the annual AACR American Association for Cancer Research meeting in Washington D.C.
Poster: Establishment and validation of a breast cancer panel using targeted next generation bisulfite sequencing (tNGBS)
Poster Session: Tuesday, Apr 4, 2017, 1:00 PM – 5:00 PM
Booth #: 2845
Location: Convention Center, Halls A-C, Poster Section 15
February 13-16, 2017 – AGBT Advances in Genome Biology and Technology
EpigenDx will be attending the annual AGBT Advances in Genome Biology and Technology meeting in Hollywood, Florida
November 10-12, 2016 – AMP Association for Molecular Pathology
EpigenDx will be attending the annual AMP Association for Molecular Pathology 2016 meeting in Charlotte, North Carolina
Poster: Comparison of KRAS mutation detection technologies
October 18-22, 2016 – ASHG American Society of Human Genetics
EpigenDx will be attending the annual ASHG American Society of Human Genetics 2016 meeting in Vancouver, B.C.
Booth #: 1511
Poster: The validation of array determined, differentially methylated CpG sites using targeted next-generation bisulfite sequencing
Location: Convention Centre, Exhibit Hall B, West Building
September 8-9, 2016 – Epigenetics Discovery Congress
EpigenDx will be attending the 2nd annual Epigenetics Discovery Congress meeting in London, UK
Presentation: Validation of Cancer Biomarkers by targeted NextGen Bisulfite Sequencing
April 16-20, 2016 – AACR American Association for Cancer Research
EpigenDx will be attending the annual AACR American Association for Cancer Research 2016 meeting in New Orleans, Louisiana
EpigenDx Booth #: 2214
March 6-11, 2016 – Molecular Medicine Tri-Con
EpigenDx will be attending the 2016 Molecular Medicine Tri-Con in San Francisco, CA and will be participating in the poster session from March 7 to March 9
Poster: Development of Quantitative and High Throughput Targeted Next-Gen Bisulfite Sequencing Panels
September 11, 2015 – CLIA Certification
Press Release: EpigenDx Inc. approved for KRAS mutation genetic testing.
July 20, 2015 – EpiGenie
Feature Article: Salivating Insights into the DNA Methylation Connection in Fetal Alcohol Syndrome
April 18-22, 2015 – AACR 2015
EpigenDx will be attending the American Association for Cancer Research (AACR) Annual Meeting: April 18-22, 2015 in Philadelphia, Pennsylvania.
Exhibit: Booth #1815
Location: Philadelphia Convention Center
October 19-21, 2014 – ASHG 2014
EpigenDx will be attending the American Society of Human Genetics (ASHG) 2014: October 19-21 in San Diego, California.
Poster: A Custom 5m-Seq™ Immunology NGS Panel to Detect Epigenetic Signatures in Various Cancer Types
Poster: A Custom 5m-Seq™ Cancer NGS Panel to Detect Epigenetic Signatures of Various Cancer Types
June 23-26, 2014 – BIO International Covention 2014
Epigendx will be attending the BIO International Convention 2014: June 23-26 at San Diego, California
June 18-21, 2014 – ISSCR 2014
EpigenDx will be attending the International Society for Stem Cell Research (ISSCR) 2014: June 18-21 in Vancouver, Canada.
April 6-9, 2014 – AACR Annual Meeting 2014
EpigenDx will be attending the American Association for Cancer Research (AACR) 2014: in San Diego, CA.
Poster: Methylation, copy number, and LOH analysis of Chr1q21.3 for discovery of ovarian and breast cancer biomarkers
Session ID: Molecular and Cellular Biology 5
February 12-15, 2014 – AGBT 2014
EpigenDx will be attending the Advances in Genome Biology and Technology (AGBT) 2014 : February 12-15 in Marco Island, Florida.
February 10-12, 2014 – Molecular Medicine Tri-Conference 2014
EpigenDx will be attending the Molecular Medicine Tri-Conference (Tri-Con) 2014: February 10-12 at the Moscone North Convention Center in San Francisco, CA.
Exhibit: Booth #714
October 22-26, 2013 – ASHG 2013
EpigenDx will be attending the American Society of Human Genetics (ASHG) Annual Meeting 2013: October 22-26 at the Boston Convention and Exhibition Center (BCEC) in Boston, MA.
Exhibit: Booth #620
Abstract title: The combination of genome wide screening and DNA methylation in the determination of bio-marker discovery in ovarian and breast cancer.
June 12-15, 2013 – ISSCR 2013 Annual Meeting
EpigenDx will be attending the International Society for Stem Cell Research (ISSCR) 2013 meeting from June 12-15, 2013 at the Boston Convention and Exhibition Center (BCEC) in Boston, MA.
Exhibit: Booth #831.
April 6-10, 2013 – AACR 2013
EpigenDx will be attending AACR Anual Meeting 2013: April 6th – 10th, at Washington DC.
Exhibit: Booth #909
Poster/Abstract Number: 4242
Session ID: Molecular and Cellular Biology 55
Location: Hall A-C, Poster Section 32
November 7-9, 2012 – ASHG 2012 Annual Meeting
EpigenDx will be attending ASHG 2012: November 7th – 9th, San Francisco, CA.
Exhibit: 10:00 AM to 4:30 PM daily, Booth #721 (located one row behind and two rows to the left of ASHG Central when entering the front of the exhibit hall).
Poster #3425T: Thursday November 8th 2:15 PM to 3:15 PM (Category: Epigenetics)
15th August 2012 – Affymetrix Microarray Services
EpigenDx is pleased to introduce microarray services using the Affymetrix GeneChip instrument system.
15th August 2012 – FoxP3 Methylation Assay
EpigenDx has launched a new product kit for the FoxP3 methylation assay. See our product listing for more details.
15th August 2012 – New Hopkinton Site
EpigenDx has recently relocated to its new site in Hopkinton, Massachusetts. Our new address is: 96 South Street, Hopkinton, MA 01748.